论文部分内容阅读
目的:探讨糖类抗原CA125、CEA与CA199联合检测对卵巢癌有一定的鉴别诊断价值。方法:应用化学发光免疫法对126例经病理查证实的卵巢癌患者(试验组)、104例良性肿瘤患者(对照组)进行血清CA125、CEA与CA199检测。结果:试验组血清检测结果和阳性率均明显高于对照组(P<0.01),联合检测阳性率高于单项检测(P<0.01)。结论:应用检验医学进行CA125、CEA与CA199联合检测对卵巢癌有一定的鉴别诊断价值。可降低误诊率。
Objective: To investigate the differential diagnosis value of carbohydrate antigen CA125, CEA and CA199 in ovarian cancer. Methods: Serum CA125, CEA and CA199 were detected in 126 patients with ovarian cancer (experimental group) and 104 patients with benign tumor (control group) by chemiluminescence immunoassay. Results: The serum test results and the positive rate in the test group were significantly higher than those in the control group (P <0.01). The positive rate of the combined test was higher than that of the single test (P <0.01). Conclusion: The combined detection of CA125, CEA and CA199 by laboratory medicine has certain differential value in the diagnosis of ovarian cancer. Can reduce the misdiagnosis rate.